Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
EGLE
|
Gary Vogel
Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 8,024 Reduced 4.77% |
$152,456
$19.0 p/Share
|
Jan 02
2021 |
|
TBI
|
Garrett Ferencz
EVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct | 407 Reduced 1.01% |
$7,607
$18.69 p/Share
|
Jan 02
2021 |
|
RPT
|
Brian Harper
CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct | 7,545 Reduced 1.41% |
$65,264
$8.65 p/Share
|
Jan 02
2021 |
|
RPT
|
Michael Fitzmaurice
EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct | 2,106 Reduced 1.42% |
$18,217
$8.65 p/Share
|
Jan 02
2021 |
|
RPT
|
Timothy Collier
Executive VP-Leasing |
SELL
Payment of exercise price or tax liability
|
Direct | 1,824 Reduced 3.49% |
$15,778
$8.65 p/Share
|
Jan 02
2021 |
|
RPT
|
Heather Ohlberg
EVP, Gen. Counsel, Secretary |
SELL
Payment of exercise price or tax liability
|
Direct | 1,803 Reduced 8.95% |
$15,596
$8.65 p/Share
|
Jan 02
2021 |
|
BCOR
|
Ann J. Bruder
Chief Legal Officer & Sec'y |
SELL
Payment of exercise price or tax liability
|
Direct | 1,376 Reduced 2.12% |
$20,901
$15.19 p/Share
|
Jan 02
2021 |
|
BCOR
|
Curtis A Campbell
President Software |
SELL
Payment of exercise price or tax liability
|
Direct | 1,389 Reduced 2.46% |
$21,099
$15.19 p/Share
|
Jan 02
2021 |
|
IMAX
|
Richard L Gelfond
Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 17,617 Reduced 5.16% |
$317,458
$18.02 p/Share
|
Jan 02
2021 |
|
IMAX
|
Richard L Gelfond
Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 44,715 Added 11.57% |
-
|
Jan 02
2021 |
|
GEL
|
Kenneth M Jastrow Ii
Director |
SELL
Sale (or disposition) back to the issuer
|
Direct | 1,232 Reduced 0.81% |
$8,378
$6.8 p/Share
|
Jan 02
2021 |
|
GEL
|
Kenneth M Jastrow Ii
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 1,232 Added 0.81% |
-
|
Jan 02
2021 |
|
GEL
|
Sharilyn S Gasaway
Director |
SELL
Sale (or disposition) back to the issuer
|
Direct | 1,232 Reduced 0.43% |
$8,378
$6.8 p/Share
|
Jan 02
2021 |
|
GEL
|
Sharilyn S Gasaway
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 1,232 Added 0.42% |
-
|
Jan 02
2021 |
|
GEL
|
James E Davison
Director |
SELL
Sale (or disposition) back to the issuer
|
Direct | 1,095 Reduced 0.04% |
$7,446
$6.8 p/Share
|
Jan 02
2021 |
|
GEL
|
James E Davison
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 1,095 Added 0.04% |
-
|
Jan 02
2021 |
|
GEL
|
James E. Davison Jr.
Director |
SELL
Sale (or disposition) back to the issuer
|
Direct | 1,095 Reduced 0.03% |
$7,446
$6.8 p/Share
|
Jan 02
2021 |
|
GEL
|
James E. Davison Jr.
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 1,095 Added 0.03% |
-
|
Jan 02
2021 |
|
GEL
|
Conrad P Albert
Director |
SELL
Sale (or disposition) back to the issuer
|
Direct | 1,122 Reduced 6.96% |
$7,630
$6.8 p/Share
|
Jan 02
2021 |
|
GEL
|
Conrad P Albert
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 1,122 Added 6.51% |
-
|
Jan 02
2021 |
|
GEL
|
Jack T Taylor
Director |
SELL
Sale (or disposition) back to the issuer
|
Direct | 1,122 Reduced 3.3% |
$7,630
$6.8 p/Share
|
Jan 02
2021 |
|
GEL
|
Jack T Taylor
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 1,122 Added 3.2% |
-
|
Jan 02
2021 |
|
NBR
|
William J Restrepo
Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 9,776 Added 12.28% |
-
|
Jan 02
2021 |
|
NBR
|
William J Restrepo
Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct | 2,100 Reduced 3.38% |
-
|
Jan 02
2021 |
|
PLAB
|
Mary Paladino |
BUY
Grant, award, or other acquisition
|
Direct | 12,000 Added 30.77% |
-
|
Jan 02
2021 |
|
PLAB
|
Constantine S Macricostas |
BUY
Grant, award, or other acquisition
|
Direct | 12,000 Added 2.24% |
-
|
Jan 02
2021 |
|
PLAB
|
Mitchell G Tyson |
BUY
Grant, award, or other acquisition
|
Direct | 12,000 Added 10.4% |
-
|
Jan 02
2021 |
|
PLAB
|
Daniel Jl Liao |
BUY
Grant, award, or other acquisition
|
Direct | 12,000 Added 40.0% |
-
|
Jan 02
2021 |
|
PLAB
|
Walter M Fiederowicz |
BUY
Grant, award, or other acquisition
|
Direct | 12,000 Added 30.77% |
-
|
Jan 02
2021 |
|
PLAB
|
George Macricostas
CEO |
BUY
Grant, award, or other acquisition
|
Direct | 12,000 Added 17.65% |
-
|
Jan 02
2021 |
|
PLAB
|
Kang Jyh Lee |
BUY
Grant, award, or other acquisition
|
Direct | 35,000 Added 15.47% |
-
|
Jan 02
2021 |
|
PLAB
|
Peter S Kirlin
Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct | 85,000 Added 16.2% |
-
|
Jan 02
2021 |
|
NTUS
|
Austin Francis Noll Iii
Executive VP and CCO |
SELL
Payment of exercise price or tax liability
|
Direct | 6,704 Reduced 7.15% |
$134,348
$20.04 p/Share
|
Jan 02
2021 |
|
NTUS
|
Dong Chune Christopher Chung
Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 5,263 Reduced 3.4% |
$105,471
$20.04 p/Share
|
Jan 02
2021 |
|
ROCK
|
William T Bosway
President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 4,237 Reduced 24.33% |
$304,810
$71.94 p/Share
|
Jan 02
2021 |
|
ROCK
|
William T Bosway
President and CEO |
BUY
Grant, award, or other acquisition
|
Direct | 9,343 Added 34.92% |
-
|
Jan 02
2021 |
|
ROCK
|
William T Bosway
President and CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct | 9,343 Reduced 50.0% |
-
|
Jan 02
2021 |
|
NVRO
|
Kashif Rashid
SVP, Corp Dev and CLO |
SELL
Payment of exercise price or tax liability
|
Direct | 1,365 Reduced 4.57% |
$236,282
$173.1 p/Share
|
Jan 02
2021 |
|
WGO
|
Stacy L Bogart
SVP-GENERAL COUNSEL |
SELL
Payment of exercise price or tax liability
|
Direct | 1,136 Reduced 5.25% |
$69,500
$61.18 p/Share
|
Jan 02
2021 |
|
GTN
|
Hilton H Howell Jr
Chairman, President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 63,831 Reduced 8.73% |
$1,141,937
$17.89 p/Share
|
Jan 02
2021 |
|
GTN
|
Robin Robinson Howell |
SELL
Payment of exercise price or tax liability
|
Indirect | 63,831 Reduced 8.73% |
$1,141,937
$17.89 p/Share
|
Jan 02
2021 |
|
GTN
|
Kevin Paul Latek
EVP Chief L & D Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 32,122 Reduced 10.4% |
$574,663
$17.89 p/Share
|
Jan 02
2021 |
|
GTN
|
James C Ryan
EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 26,362 Reduced 6.38% |
$471,616
$17.89 p/Share
|
Jan 02
2021 |
|
GTN
|
Robert Lawrence Smith |
SELL
Payment of exercise price or tax liability
|
Direct | 18,879 Reduced 9.77% |
$337,745
$17.89 p/Share
|
Jan 02
2021 |
|
THRM
|
Matteo Anversa
EVP, CFO, Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct | 484 Reduced 3.92% |
$31,566
$65.22 p/Share
|
Jan 02
2021 |
|
CIM
|
Robert S Colligan
Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 31,298 Added 10.05% |
-
|
Jan 02
2021 |
|
CIM
|
Phillip John Kardis Ii
President and CEO |
BUY
Grant, award, or other acquisition
|
Direct | 46,947 Added 16.02% |
-
|
Jan 02
2021 |
|
CIM
|
Choudhary Yarlagadda
Pres. COO, Co-CIO |
BUY
Grant, award, or other acquisition
|
Direct | 556,336 Added 31.99% |
-
|
Jan 02
2021 |
|
CIM
|
Mohit Marria
CEO & Chief Investment Officer |
BUY
Grant, award, or other acquisition
|
Direct | 547,421 Added 35.82% |
-
|
Jan 02
2021 |
|
PD
|
Jennifer Tejada
Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 7,887 Reduced 2.49% |
$328,888
$41.7 p/Share
|
Jan 02
2021 |